Integrated Kidney Care of South Florida, LLC
KCE Located In: Florida
Participant Groups and Providers
ABRAHAM BICHACHI, M.D., P.A.
ABRAHAM BICHACHI
CHARLOTTE NEPHROLOGY ASSOCIATES PA
JAIDEEP HINGORANI
LALITA THATTE
COMPREHENSIVE NEPHROLOGY SPECIALIST LLC
FARHAN ABID
DR HASSAN ALI MD PA
BRIAN ABAROA
HASSAN ALI
DUSAN DRAGOVIC, MD, FASN, LLC
DUSAN DRAGOVIC
JAYESH S SHAH, MD LLC
JAYESH SHAH
KIDNEY AND HYPERTENSION SPECIALIST OF MIAMI PA
ALEXANDER VELAR
ANNE MARIE MILES
CYNTHIA PALOMINO RIVAS
JONATHAN DA COSTA
JORGE MORDUJOVICH
MICHAEL LEMONT
SEYMOUR FRANKFURT
KIDNEY PLUS, PLLC
ABDUR BAIG
LIVING STONE NEPHROLOGY AND HYPERTENSION CONSULTANTS INC
IFEANYI ISAIAH
NORTH MIAMI KIDNEY CENTER, LLC
ROBENSON JEAN MARIE
RICHARD SANDLER MD PA
RICHARD SANDLER
SOUTH FLORIDA KIDNEY ASSOCIATES PA
MAX BENJAMIN
UNIVERSITY OF MIAMI
ADELA MATTIAZZI
ADRIANA DEJMAN VALDEZ
ALESSIA FORNONI
ARACELI MONEDA
DAVID ROTH
EFREN CHAVEZ MORALES
ELIAS FERNANDEZ
FELIX HERNANDEZ
FRANCO CABEZA RIVERA
GABRIEL CONTRERAS
GISELLE GUERRA
JAIR MUNOZ MENDOZA
JAVIER PAGAN GUTIERREZ
JEAN JEANTY
JUAN DUQUE BALLESTEROS
LUMEN MENDEZ CASTANER
MARCO LADINO AVELLANEDO
MARIELLA ORTIGOSA-GOGGINS
OLIVER LENZ
PURA TEIXEIRO
SHOBANA SIVAN
WARREN KUPIN
YELENA DREXLER
ZAIN MITHANI
Preferred Groups and Providers
VILLAGEHEALTH DM LLC
ALFRED TETTEH
BIRGET CORDIS
GARDINE JACQUES
KEMILLE BELL
LATERRIE PATTERSON
HEATHER ANDERSON
MELANIE GRIZZARD
MELISSA ROONEY
NWAEBUNI OKEKE
ORETHA SOGBIE
ROBYN BISHOP
ANNIA ASENCIO
RUTH ADAM
Governing Body Designees
Clinical and Administrative Leadership
Josephine Kolajo-Garcon
Primary Contact & Administrative Leader
Director, DaVita IKC
Oliver Lenz
KCE Clinical Leader
University of Miami
Quality Measures
Information for the following performance measures will be available by February 1st, 2024.
- The Depression Response measure is a patient-reported outcome measure that assesses the percentage of adult patients (18 years of age or older) who score >9 on the Patient Health Questionnaire (PHQ-9), have a diagnosis of major depression or dysthymia and who demonstrate a response to treatment at approximately 12 months.
- The Patient Activation Measure (PAM) licensed through Insignia Health (a Phreesia company), assesses the attitudes, motivators, and behaviors that allow a patient to manage his or her healthcare issues. Patient activation is essential to achieving improved health outcomes and cost control.
- Optimal ESRD Starts quantifies the ability of healthcare providers to prepare patients for ESRD by educating them and their families about the need for dialysis or kidney transplant, helping them to make appropriate and informed choices about their treatment modality, and supporting them in successfully transitioning to dialysis or kidney transplantation as kidney function declines.
Shared Savings and Losses
Information for the following performance measures will be available by February 1st, 2024.
- Total amount of Shared Savings or Shared Losses per Performance Year
- Proportion of Shared Savings invested in the program and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries
- Proportion of Shared Savings to KCE Participants and Preferred Providers for each Performance Year
For a full list of facilities and joint ventures, please click here.
For more information on CKCC, click here.